OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod)
Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 4, pp. 1020-1028
Open Access | Times Cited: 16
Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 4, pp. 1020-1028
Open Access | Times Cited: 16
Showing 16 citing articles:
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
Furio Pacini, Dagmar Führer, Rossella Elisei, et al.
European Thyroid Journal (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 79
Furio Pacini, Dagmar Führer, Rossella Elisei, et al.
European Thyroid Journal (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 79
Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]
Barbara Jarząb, Marek Dedecjus, Andrzej Lewiński, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 2, pp. 173-300
Open Access | Times Cited: 40
Barbara Jarząb, Marek Dedecjus, Andrzej Lewiński, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 2, pp. 173-300
Open Access | Times Cited: 40
Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer
Sohyun Park, Ji-In Bang, Keunyoung Kim, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 3, pp. e96-e104
Closed Access | Times Cited: 5
Sohyun Park, Ji-In Bang, Keunyoung Kim, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 3, pp. e96-e104
Closed Access | Times Cited: 5
MANAGEMENT OF ENDOCRINE DISEASE: The role of rhTSH in the management of differentiated thyroid cancer: pros and cons
Luca Giovanella, Leonidas H. Duntas
European Journal of Endocrinology (2019) Vol. 181, Iss. 4, pp. R133-R145
Open Access | Times Cited: 27
Luca Giovanella, Leonidas H. Duntas
European Journal of Endocrinology (2019) Vol. 181, Iss. 4, pp. R133-R145
Open Access | Times Cited: 27
Tailoring the approach to radioactive iodine treatment in thyroid cancer
Sarah E. Mayson, Christine M. Chan, Bryan R. Haugen
Endocrine Related Cancer (2021) Vol. 28, Iss. 10, pp. T125-T140
Open Access | Times Cited: 22
Sarah E. Mayson, Christine M. Chan, Bryan R. Haugen
Endocrine Related Cancer (2021) Vol. 28, Iss. 10, pp. T125-T140
Open Access | Times Cited: 22
SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management—the EANM perspective
Petra Petranović Ovčariček, Michael C. Kreißl, Alfredo Campennì, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 12, pp. 3959-3963
Open Access | Times Cited: 15
Petra Petranović Ovčariček, Michael C. Kreißl, Alfredo Campennì, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 12, pp. 3959-3963
Open Access | Times Cited: 15
Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies
Hannelore I. Coerts, Bart de Keizer, Robert J. Marlowe, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 2, pp. R23-R35
Closed Access | Times Cited: 9
Hannelore I. Coerts, Bart de Keizer, Robert J. Marlowe, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 2, pp. R23-R35
Closed Access | Times Cited: 9
Radioiodine therapy in the different stages of differentiated thyroid cancer
Laura Valerio, Fabio Maino, Maria Grazia Castagna, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 1, pp. 101703-101703
Closed Access | Times Cited: 14
Laura Valerio, Fabio Maino, Maria Grazia Castagna, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 1, pp. 101703-101703
Closed Access | Times Cited: 14
Advanced imaging and theranostics in thyroid cancer
Molly E. Roseland, Yuni K. Dewaraja, Ka Kit Wong
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 29, Iss. 5, pp. 456-465
Open Access | Times Cited: 12
Molly E. Roseland, Yuni K. Dewaraja, Ka Kit Wong
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 29, Iss. 5, pp. 456-465
Open Access | Times Cited: 12
Summary and update on the management of differentiated thyroid cancer in 2023
Perrine Raymond, Marc Klein, Françoise Borson‐Chazot
Annales d Endocrinologie (2024) Vol. 85, Iss. 2, pp. 110-117
Closed Access | Times Cited: 2
Perrine Raymond, Marc Klein, Françoise Borson‐Chazot
Annales d Endocrinologie (2024) Vol. 85, Iss. 2, pp. 110-117
Closed Access | Times Cited: 2
Exploring the oral‐gut microbiota during thyroid cancer: Factors affecting the thyroid functions and cancer development
Kun Yao, Wei Xiaodong, Wang Hai-jun, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 10, pp. 5657-5674
Open Access | Times Cited: 5
Kun Yao, Wei Xiaodong, Wang Hai-jun, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 10, pp. 5657-5674
Open Access | Times Cited: 5
Recombinant Human Thyrotropin Plus Radioactive Iodine Among Patients With Thyroid Cancer
Hui Tan, Yushen Gu, Yan Xiu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2443407-e2443407
Open Access
Hui Tan, Yushen Gu, Yan Xiu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2443407-e2443407
Open Access
Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis
Qingqiang Yao, Lili Song, Jun Xu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Qingqiang Yao, Lili Song, Jun Xu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions
Lihua Fang, Jie Ning
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Lihua Fang, Jie Ning
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Role of 131I in low-risk differentiated thyroid cancer
Juan A. Vallejo
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2022) Vol. 42, Iss. 1, pp. 33-37
Closed Access | Times Cited: 2
Juan A. Vallejo
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2022) Vol. 42, Iss. 1, pp. 33-37
Closed Access | Times Cited: 2
Papel del 131I en el cáncer diferenciado de tiroides de bajo riesgo
Juan A. Vallejo
Revista Española de Medicina Nuclear e Imagen Molecular (2022) Vol. 42, Iss. 1, pp. 33-37
Closed Access
Juan A. Vallejo
Revista Española de Medicina Nuclear e Imagen Molecular (2022) Vol. 42, Iss. 1, pp. 33-37
Closed Access
